Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119652522> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2119652522 endingPage "209" @default.
- W2119652522 startingPage "205" @default.
- W2119652522 abstract "The combination of vinorelbine and doxorubicin, two very active drugs in metastatic breast cancer, has demonstrated impressive results in terms of efficacy, at the price of cardiac toxicity (10% grades 2-4) due to the cumulative dose of doxorubicin delivered. This study was designed to divide the dose of doxorubicin into two administrations (day 1 and 8) in order to reduce the toxicity profile, while keeping the same level of efficacy.Thirty-eight chemotherapy-naïve metastatic breast cancer patients entered into the study and were treated with vinorelbine, 25 mg/m(2), and doxorubicin, 25 mg/m(2), both on days 1 and 8, every 3 weeks. Thirty-seven patients were evaluable for efficacy and 38 for tolerance; 71% of the patients presented with visceral metastases.Patients received a median of seven cycles and 94.9% of the intended dose intensity of both drugs. Grade 3-4 neutropenia was reported in 10% of cycles. Alopecia was reported in 89.5% of the patients, and grade 2 nausea/vomiting in 9.3% of the cycles. Grade 1-2 cardiac toxicity was noted in 23.7% of the patients. The objective response rate of the patients was 78.4% (nearly 81% for patients with visceral metastases); the median duration of response was 11.6 months, the median survival 21.6 months, and the 1-year survival 75.2%.This schedule of vinorelbine/doxorubicin represents an active and well-tolerated combination." @default.
- W2119652522 created "2016-06-24" @default.
- W2119652522 creator A5026055104 @default.
- W2119652522 creator A5030920479 @default.
- W2119652522 creator A5039505423 @default.
- W2119652522 creator A5041747015 @default.
- W2119652522 creator A5056618108 @default.
- W2119652522 creator A5088536972 @default.
- W2119652522 date "2002-06-01" @default.
- W2119652522 modified "2023-09-28" @default.
- W2119652522 title "A Phase II Study of Intravenous Navelbine and Doxorubicin Combination in Previously Untreated Advanced Breast Carcinoma" @default.
- W2119652522 cites W1843618725 @default.
- W2119652522 cites W1918151945 @default.
- W2119652522 cites W1993420453 @default.
- W2119652522 cites W2051297618 @default.
- W2119652522 cites W206480088 @default.
- W2119652522 cites W2080282739 @default.
- W2119652522 cites W2092583651 @default.
- W2119652522 cites W2093596089 @default.
- W2119652522 cites W2164203329 @default.
- W2119652522 cites W2169073956 @default.
- W2119652522 cites W2176579253 @default.
- W2119652522 cites W2271753451 @default.
- W2119652522 cites W2293688022 @default.
- W2119652522 doi "https://doi.org/10.1634/theoncologist.7-3-205" @default.
- W2119652522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12065792" @default.
- W2119652522 hasPublicationYear "2002" @default.
- W2119652522 type Work @default.
- W2119652522 sameAs 2119652522 @default.
- W2119652522 citedByCount "9" @default.
- W2119652522 countsByYear W21196525222012 @default.
- W2119652522 countsByYear W21196525222014 @default.
- W2119652522 crossrefType "journal-article" @default.
- W2119652522 hasAuthorship W2119652522A5026055104 @default.
- W2119652522 hasAuthorship W2119652522A5030920479 @default.
- W2119652522 hasAuthorship W2119652522A5039505423 @default.
- W2119652522 hasAuthorship W2119652522A5041747015 @default.
- W2119652522 hasAuthorship W2119652522A5056618108 @default.
- W2119652522 hasAuthorship W2119652522A5088536972 @default.
- W2119652522 hasBestOaLocation W21196525221 @default.
- W2119652522 hasConcept C121608353 @default.
- W2119652522 hasConcept C126322002 @default.
- W2119652522 hasConcept C141071460 @default.
- W2119652522 hasConcept C143998085 @default.
- W2119652522 hasConcept C151032500 @default.
- W2119652522 hasConcept C2775930923 @default.
- W2119652522 hasConcept C2776694085 @default.
- W2119652522 hasConcept C2777063308 @default.
- W2119652522 hasConcept C2778233292 @default.
- W2119652522 hasConcept C2778239845 @default.
- W2119652522 hasConcept C2780350996 @default.
- W2119652522 hasConcept C2780580376 @default.
- W2119652522 hasConcept C2780852908 @default.
- W2119652522 hasConcept C2781303535 @default.
- W2119652522 hasConcept C29730261 @default.
- W2119652522 hasConcept C31760486 @default.
- W2119652522 hasConcept C530470458 @default.
- W2119652522 hasConcept C71924100 @default.
- W2119652522 hasConcept C90924648 @default.
- W2119652522 hasConceptScore W2119652522C121608353 @default.
- W2119652522 hasConceptScore W2119652522C126322002 @default.
- W2119652522 hasConceptScore W2119652522C141071460 @default.
- W2119652522 hasConceptScore W2119652522C143998085 @default.
- W2119652522 hasConceptScore W2119652522C151032500 @default.
- W2119652522 hasConceptScore W2119652522C2775930923 @default.
- W2119652522 hasConceptScore W2119652522C2776694085 @default.
- W2119652522 hasConceptScore W2119652522C2777063308 @default.
- W2119652522 hasConceptScore W2119652522C2778233292 @default.
- W2119652522 hasConceptScore W2119652522C2778239845 @default.
- W2119652522 hasConceptScore W2119652522C2780350996 @default.
- W2119652522 hasConceptScore W2119652522C2780580376 @default.
- W2119652522 hasConceptScore W2119652522C2780852908 @default.
- W2119652522 hasConceptScore W2119652522C2781303535 @default.
- W2119652522 hasConceptScore W2119652522C29730261 @default.
- W2119652522 hasConceptScore W2119652522C31760486 @default.
- W2119652522 hasConceptScore W2119652522C530470458 @default.
- W2119652522 hasConceptScore W2119652522C71924100 @default.
- W2119652522 hasConceptScore W2119652522C90924648 @default.
- W2119652522 hasIssue "3" @default.
- W2119652522 hasLocation W21196525221 @default.
- W2119652522 hasLocation W21196525222 @default.
- W2119652522 hasOpenAccess W2119652522 @default.
- W2119652522 hasPrimaryLocation W21196525221 @default.
- W2119652522 hasRelatedWork W1980701009 @default.
- W2119652522 hasRelatedWork W1984548931 @default.
- W2119652522 hasRelatedWork W2006876985 @default.
- W2119652522 hasRelatedWork W2040967527 @default.
- W2119652522 hasRelatedWork W2119652522 @default.
- W2119652522 hasRelatedWork W2410911467 @default.
- W2119652522 hasRelatedWork W2415072220 @default.
- W2119652522 hasRelatedWork W2435036740 @default.
- W2119652522 hasRelatedWork W2438279308 @default.
- W2119652522 hasRelatedWork W2415089064 @default.
- W2119652522 hasVolume "7" @default.
- W2119652522 isParatext "false" @default.
- W2119652522 isRetracted "false" @default.
- W2119652522 magId "2119652522" @default.
- W2119652522 workType "article" @default.